Ajwah Ibrahim, Alshehri Sameerah, Alremthi Fahad, Alahmari Nasser
Department of Endocrinology, Diabetes and Metabolism, King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs, Riyadh, SAU.
Department of Internal Medicine, King Salman Armed Forces Hospital, Ministry of Defense, Tabuk, SAU.
Cureus. 2023 Feb 20;15(2):e35206. doi: 10.7759/cureus.35206. eCollection 2023 Feb.
Graves' disease (GD) is an autoimmune thyroid disease, which is considered the most common cause of primary hyperthyroidism. GD usually manifests with symptoms such as tremors, palpitations, heat intolerance, weight loss, and specific signs on physical examination (proptosis and pretibial myxedema). However, systemic involvement is also recognized, for example, hepatic involvement in patients with GD may range from asymptomatic laboratory findings of liver function derangement (either transaminases elevations or intrahepatic cholestasis) up to hepatic failure. We describe a rare case of Graves' thyrotoxicosis presenting with severe cholestasis and non-parathyroid hormone-related hypercalcemia. An extensive evaluation for hepatobiliary causes of cholestasis, including hepatic biopsy, was entirely negative. The patient was successfully treated with methimazole with subsequent clinical and biochemical improvement.
格雷夫斯病(GD)是一种自身免疫性甲状腺疾病,被认为是原发性甲状腺功能亢进最常见的病因。GD通常表现为震颤、心悸、不耐热、体重减轻等症状以及体格检查中的特定体征(突眼和胫前黏液性水肿)。然而,也认识到存在全身受累情况,例如,GD患者的肝脏受累范围可从肝功能紊乱的无症状实验室检查结果(转氨酶升高或肝内胆汁淤积)到肝衰竭。我们描述了一例罕见的格雷夫斯甲状腺毒症病例,该病例表现为严重胆汁淤积和非甲状旁腺激素相关的高钙血症。对胆汁淤积的肝胆病因进行的广泛评估,包括肝活检,结果均为阴性。该患者用甲巯咪唑成功治疗,随后临床和生化指标均有改善。